The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in patients with pancreatic and ampullary cancer whose tumors harbor pathogenic APC mutations.
 
Christopher Pishvaian
Stock and Other Ownership Interests - Perthera (I)
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (I); IDEAYA Biosciences (I); Merck (I); Merus (I); Novartis (I); Pfizer (I); Seattle Genetics/Astellas (I); TriSalus Life Sciences (I)
Patents, Royalties, Other Intellectual Property - Perthera (I)
Travel, Accommodations, Expenses - Astellas Pharma (I); RenovoRx (I)
 
Thomas McPhaul
No Relationships to Disclose
 
Dea Cunningham
No Relationships to Disclose
 
Lei Zheng
Stock and Other Ownership Interests - Alphamab; Mingruizhiyao; Z and L International Medical
Consulting or Advisory Role - Alphamab; Ambrx; AstraZeneca; BioArdis; Biosynergies; Coherent; datarevive; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Merrimack; Mingruizhiyao; NovaGenesis; novarock; Snow Lake Capital; Xilio Therapeutics
Research Funding - Amgen; AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
Other Relationship - QED Therapeutics
 
Dan Laheru
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Dung T. Le
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; HalioDX; Janssen; Merck; Merus NV; Nouscom
Research Funding - Abbvie (Inst); Aduro Biotech; Bristol-Myers Squibb; Curegenix; Medivir; Merck; Nouscom (Inst)
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".
 
Ilene S. Browner
No Relationships to Disclose
 
William Burns
Research Funding - Bristol-Myers Squibb (Inst)
 
Richard Burkhart
No Relationships to Disclose
 
Kelly Lafaro
No Relationships to Disclose
 
Amol Narang
Research Funding - Boston Scientific; Nanocan Therapeutics
 
Jin He
Research Funding - Abbvie (Inst)
 
Valerie Lee
Research Funding - Merck (Inst); Novartis (Inst)
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera; Targeting Resistance in Cancer Cooperative; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; IDEAYA Biosciences; Merck; Merus; Novartis; Pfizer; Seagen; TriSalus Life Sciences
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); RenovoRx (Inst); RenovoRx (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Astellas Pharma; RenovoRx